These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 8675219)

  • 21. IL-4 and anti-CD40 protect against Fas-mediated B cell apoptosis and induce B cell growth and differentiation.
    Nakanishi K; Matsui K; Kashiwamura S; Nishioka Y; Nomura J; Nishimura Y; Sakaguchi N; Yonehara S; Higashino K; Shinka S
    Int Immunol; 1996 May; 8(5):791-8. PubMed ID: 8671668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B cells activated via CD40 and IL-4 undergo a division burst but require continued stimulation to maintain division, survival and differentiation.
    Rush JS; Hodgkin PD
    Eur J Immunol; 2001 Apr; 31(4):1150-9. PubMed ID: 11298340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct molecular mechanisms of Fas resistance in murine B lymphoma cells.
    Mueller CM; Scott DW
    J Immunol; 2000 Aug; 165(4):1854-62. PubMed ID: 10925264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential modulation of cyclin-dependent kinase inhibitor p27Kip1 by negative signaling via the antigen receptor of B cells and positive signaling via CD40.
    Han H; Nomura T; Honjo T; Tsubata T
    Eur J Immunol; 1996 Oct; 26(10):2425-32. PubMed ID: 8898956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct role of follicular dendritic cells and T cells in the proliferation, differentiation, and apoptosis of a centroblast cell line, L3055.
    Choe J; Li L; Zhang X; Gregory CD; Choi YS
    J Immunol; 2000 Jan; 164(1):56-63. PubMed ID: 10604993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dominant signals leading to inhibitor kappaB protein degradation mediate CD40 ligand rescue of WEHI 231 immature B cells from receptor-mediated apoptosis.
    Schauer SL; Bellas RE; Sonenshein GE
    J Immunol; 1998 May; 160(9):4398-405. PubMed ID: 9574544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway.
    Schattner EJ; Elkon KB; Yoo DH; Tumang J; Krammer PH; Crow MK; Friedman SM
    J Exp Med; 1995 Nov; 182(5):1557-65. PubMed ID: 7595225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD28 co-stimulation stabilizes the expression of the CD40 ligand on T cells.
    Johnson-Léger C; Christensen J; Klaus GG
    Int Immunol; 1998 Aug; 10(8):1083-91. PubMed ID: 9723694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of bcl-x by CD40 engagement rescues sIg-induced apoptosis in murine B cells.
    Wang Z; Karras JG; Howard RG; Rothstein TL
    J Immunol; 1995 Oct; 155(8):3722-5. PubMed ID: 7561075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new multivalent B cell activation model--anti-IgD bound to Fc gamma RI: properties and comparison with CD40L-mediated activation.
    Cho S; Conrad DH
    Int Immunol; 1997 Feb; 9(2):239-48. PubMed ID: 9040006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential regulatory effects of cAMP-elevating agents on human normal and neoplastic B cell functional response following ligation of surface immunoglobulin and CD40.
    Kelly K; Knox KA
    Cell Immunol; 1995 Nov; 166(1):93-102. PubMed ID: 7585986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multivalent, but not divalent, antigen receptor cross-linkers synergize with CD40 ligand for induction of Ig synthesis and class switching in normal murine B cells. A redefinition of the TI-2 vs T cell-dependent antigen dichotomy.
    Snapper CM; Kehry MR; Castle BE; Mond JJ
    J Immunol; 1995 Feb; 154(3):1177-87. PubMed ID: 7529792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD40 ligand-positive CD8+ T cell clones allow B cell growth and differentiation.
    Hermann P; Van-Kooten C; Gaillard C; Banchereau J; Blanchard D
    Eur J Immunol; 1995 Oct; 25(10):2972-7. PubMed ID: 7589100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of B cells with activated T cells reduces the threshold for CD40-mediated B cell activation.
    Klaus GG; Holman M; Johnson-Léger C; Christenson JR; Kehry MR
    Int Immunol; 1999 Jan; 11(1):71-9. PubMed ID: 10050675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-10 inhibits lipopolysaccharide-induced murine B cell proliferation and cross-linking of surface antigen receptors or ligation of CD40 restores the response.
    Marcelletti JF
    J Immunol; 1996 Oct; 157(8):3323-33. PubMed ID: 8871628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of mitogen-activated protein kinases via CD40 is distinct from that stimulated by surface IgM on B cells.
    Kashiwada M; Kaneko Y; Yagita H; Okumura K; Takemori T
    Eur J Immunol; 1996 Jul; 26(7):1451-8. PubMed ID: 8766546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of CD5 in Th1 and Th2 contact-mediated rescue of anti-mu and ionomycin induced growth inhibition in a B cell lymphoma.
    Muthukkumar S; Bondada S
    Int Immunol; 1995 Feb; 7(2):305-15. PubMed ID: 7537538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD40 cross-linking inhibits specific antibody production by human B cells.
    Callard RE; Herbert J; Smith SH; Armitage RJ; Costelloe KE
    Int Immunol; 1995 Nov; 7(11):1809-15. PubMed ID: 8580079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fas ligation induces apoptosis of CD40-activated human B lymphocytes.
    Garrone P; Neidhardt EM; Garcia E; Galibert L; van Kooten C; Banchereau J
    J Exp Med; 1995 Nov; 182(5):1265-73. PubMed ID: 7595197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T cell immunity to lymphoma following treatment with anti-CD40 monoclonal antibody.
    Tutt AL; O'Brien L; Hussain A; Crowther GR; French RR; Glennie MJ
    J Immunol; 2002 Mar; 168(6):2720-8. PubMed ID: 11884438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.